4//SEC Filing
Brown Edward M 4
Accession 0000914190-17-000265
CIK 0001180145other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:40 PM ET
Size
11.0 KB
Accession
0000914190-17-000265
Insider Transaction Report
Form 4
Brown Edward M
Director
Transactions
- Sale
Common Stock
2017-08-30$29.09/sh−13,031$379,063→ 114,390 total(indirect: By Trust) - Sale
Common Stock
2017-08-31$29.30/sh−6,969$204,215→ 107,421 total(indirect: By Trust)
Holdings
- 75,536
Restricted Stock Units
→ Common Stock (75,536 underlying) - 4,029
Restricted Stock Units
→ Common Stock (4,029 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.25 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.26 to $29.32 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
- [F4]Represents the aggregate number of restricted stock units (all previously reported) held by reporting person that are payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
- [F5]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,008 shares on September 30, 2017 and 1,007 shares on each of December 31, 2017, March 31, 2018 and June 30, 2018.
Documents
Issuer
Cardiovascular Systems Inc
CIK 0001180145
Entity typeother
Related Parties
1- filerCIK 0001370333
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 4:40 PM ET
- Size
- 11.0 KB